{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:53Z","timestamp":1740115073712,"version":"3.37.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege \u00dcniversitesi","doi-asserted-by":"publisher","award":["21891"],"award-info":[{"award-number":["21891"]}],"id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:40:07Z","timestamp":1715085607000},"page":"3961-3967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of antibody responses in healthcare workers before &amp; after meningococcal vaccine and determination of meningococcal carriage rates"],"prefix":"10.1016","volume":"42","author":[{"given":"Dilsah","family":"Baskol Elik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Akyol Seyhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Aytac Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-9539","authenticated-orcid":false,"given":"Aysin","family":"Zeytinoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husnu","family":"Pullukcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabire Sohret","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Tasbakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-2","key":"10.1016\/j.vaccine.2024.05.004_b0005","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2024.05.004_b0010","first-page":"29","article-title":"Disseminated meningococcal disease complicated with cardiac tamponade in a 2-month-old Infant","volume":"12","author":"Ersayo\u011flu","year":"2023","journal-title":"Mediterr J Infect Microb Antimicrob"},{"key":"10.1016\/j.vaccine.2024.05.004_b0015","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal Disease Causes and How It Spreads. https:\/\/www.cdc.gov\/meningococcal\/about\/causes-transmission.html [accessed 30 January 2024]."},{"key":"10.1016\/j.vaccine.2024.05.004_b0020","unstructured":"ECDC Surveillance report. Invasive meningococcal disease Annual Epidemiological Report for 2018. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER-Invasive-meningococcal-disease-2018.pdf [accessed 30 January 2024]."},{"issue":"9580","key":"10.1016\/j.vaccine.2024.05.004_b0025","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.004_b0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis [published correction appears in Lancet Infect Dis. 2011 Aug;11(8):584]","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.004_b0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/erv.12.29","article-title":"The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey","volume":"11","author":"Dinleyici","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2024.05.004_b0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1586\/14760584.2015.1060859","article-title":"Review of invasive meningococcal disease during the last 40 years in Turkey","volume":"14","author":"Bakir","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2024.05.004_b0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1020021109462","article-title":"Asymtomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: apropos of 1400 children sampled","volume":"17","author":"Bakir","year":"2001","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.004_b0050","first-page":"447","article-title":"Nasopharyngeal carriage rate and serogroups of Neisseria meningitidis in Turkish recruits upon entry to the military","volume":"10","author":"Basustaoglu","year":"2011","journal-title":"TAF PrevMed Bull"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0055","first-page":"17","article-title":"\u0130stanbul\u2019da Bir \u0130lkokulda Asemptomatik Neisseria meningitidis Ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131","volume":"14","author":"Punar","year":"2001","journal-title":"Klimik Derg"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.004_b0060","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/21645515.2016.1268304","article-title":"The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey","volume":"13","author":"Tekin","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2024.05.004_b0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/jmm.0.45529-0","article-title":"Neisseria meningitidis: an overview of the carriage state","volume":"53","author":"Yazdankhah","year":"2004","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00314-12","article-title":"Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj Pilgrims who had received the quadrivalent meningococcal polysaccharide","volume":"20","author":"Ceyhan","year":"2013","journal-title":"Vaccine Clin Vaccine Immunol"},{"issue":"9242","key":"10.1016\/j.vaccine.2024.05.004_b0080","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(00)03163-9","article-title":"Risk of secondary meningococcal disease in health-care workers","volume":"356","author":"Gilmore","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2024.05.004_b0085","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10096-020-03894-9","article-title":"Pharyngeal carriage rates of Neisseria meningitidis in health care professionals at a tertiary university pediatric hospital","volume":"39","author":"Steurer","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.004_b0090","unstructured":"EKMUD adult immunization guide v.3 (2023). https:\/\/www.ekmud.org.tr\/rehberler\/1-ekmud-rehberleri [accessed 30 January 2024]."},{"key":"10.1016\/j.vaccine.2024.05.004_b0095","unstructured":"World Health Organization. Control of Epidemic Meningococcal Disease: WHO Practical Guidelines 2nd edition. Geneva, Switzerland, 1998. https:\/\/www.who.int\/docs\/default-source\/documents\/publications\/control-of-epidemic-meningococcal-disease.pdf [accessed 30 January 2024]."},{"issue":"14","key":"10.1016\/j.vaccine.2024.05.004_b0100","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMcp063561","article-title":"Clinical practice. Prevention of meningococcal disease [published correction appears in N Engl J Med. 2007 Feb 1;356(5):536]","volume":"355","author":"Gardner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.004_b0105","first-page":"1","article-title":"Adequacy of sample size in health studies","author":"Lemeshow","year":"1990","journal-title":"World Health Organization"},{"key":"10.1016\/j.vaccine.2024.05.004_b0110","unstructured":"Meningitis IgG \u2013 ELISA | Dia.Pro. 2020. https:\/\/www.diapro.it\/products\/meningitis-igg-elisa\/ [accessed 30 January 2024]."},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2022.102330","article-title":"Identification of the nasopharyngeal carriage of Neisseria meningitidis by 16S rRNA Gene sequencing in asymptomatic adolescents and young adults in Cartagena, Colombia (2019\u20132020)","volume":"26","author":"Macias-Mendoza","year":"2022","journal-title":"Braz J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.004_b0120","first-page":"203","article-title":"Carriage rates of Neisseria meningitidis serogroups: determination among freshmen conscripts before vaccination","volume":"8","author":"Ataee","year":"2016","journal-title":"Iran J Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.004_b0125","first-page":"871","article-title":"Nasopharyngeal meningococcal carriage among children and adolescents in Turkey in 2018: an unexpected high serogroup X carriage","volume":"8","author":"Kizil","year":"2021","journal-title":"Children (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.004_b0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3855\/jidc.7483","article-title":"Prevalence of Neisseria meningitidis carriage: a small-scale survey in Istanbul, Turkey","volume":"10","author":"Kepenekli Kadayifci","year":"2016","journal-title":"J Infect Dev Ctries"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.004_b0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.59.5.553","article-title":"Studies on meningococcus infection: VI. The Carrier Problem","volume":"59","author":"Rake","year":"1934","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JCM.40.1.75-79.2002","article-title":"Detection of meningococcal carriage by culture and PCR of throat swabs and mouth gargles","volume":"40","author":"Jordens","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2024.05.004_b0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1099\/jmm.0.45847-0","article-title":"A novel porA-based real-time PCR for detection of meningococcal carriage","volume":"54","author":"Jordens","year":"2005","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3598-3","article-title":"Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study","volume":"19","author":"Miglietta","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0155","doi-asserted-by":"crossref","first-page":"23138","DOI":"10.1038\/s41598-021-02555-x","article-title":"Detection of Neisseria meningitidis in saliva and oropharyngeal samples from college students","volume":"11","author":"Miellet","year":"2021","journal-title":"Sci Rep."},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.004_b0160","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3201\/eid0910.030344","article-title":"Saliva and meningococcal transmission","volume":"9","author":"Orr","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2024.05.004_b0165","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1097\/INF.0000000000003660","article-title":"Impact of COVID-19 containment strategies and meningococcal conjugate ACWY vaccination on meningococcal carriage in adolescents","volume":"41","author":"McMillan","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2024.05.004_b0170","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/INF.0b013e318268dfe4","article-title":"Safety and immunogenicity of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants and toddlers: three multicenter phase III studies","volume":"31","author":"Pina","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.004_b0175","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1016\/j.ijid.2010.03.017","article-title":"Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America","volume":"14","author":"Stamboulian","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2024.05.004_b0180","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jpeds.2014.02.025","article-title":"Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents","volume":"164","author":"Baxter","year":"2014","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2021.11.045","article-title":"Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: two consecutive surveys in 2016\/17 and 2020","volume":"40","author":"Ohm","year":"2021","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2024.05.004_b0190","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1016\/j.vaccine.2010.09.092","article-title":"Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2\u201310 years of age","volume":"28","author":"Halperin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.004_b0195","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.004_b0200","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","article-title":"Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine","volume":"16","author":"Reisinger","year":"2009","journal-title":"Menactra Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.004_b0205","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40121-020-00393-4","article-title":"Post-marketing surveillance observational study of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-DT, MCV4\/Menactra\u00ae) in the Republic of Korea, 2014\u20132019","volume":"10","author":"Kim","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.05.004_b0210","unstructured":"Centers for Disease Control and Prevention (CDC). Safety Information for Meningococcal Vaccines. https:\/\/www.cdc.gov\/vaccinesafety\/vaccines\/meningococcal-vaccine.html [accessed 30 January 2024]."},{"issue":"44","key":"10.1016\/j.vaccine.2024.05.004_b0215","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.vaccine.2016.09.003","article-title":"Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine","volume":"34","author":"Robertson","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2024.05.004_b0220","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.vaccine.2019.01.008","article-title":"Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)","volume":"37","author":"Robertson","year":"2019","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.004_b0225","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"40","key":"10.1016\/j.vaccine.2024.05.004_b0230","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2020.07.039","article-title":"Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra\u00ae) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005\u20132016","volume":"38","author":"Myers","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.004_b0235","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/JCM.01428-16","article-title":"Alternative molecular methods for improved detection of meningococcal carriage and measurement of bacterial density","volume":"54","author":"Manigart","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.05.004_b0240","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/eri.11.89","article-title":"Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region","volume":"9","author":"Soriano-Gabarr\u00f3","year":"2011","journal-title":"Expert Rev Anti-Infect Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T10:22:36Z","timestamp":1728642156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":48,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24005401"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of antibody responses in healthcare workers before & after meningococcal vaccine and determination of meningococcal carriage rates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}